SPRC and NTLX Related Headlines

Go Back

Oct 22, 2026 08:59AM NeuroThera Labs completes manufacturing milestone for Tourette trial
Oct 22, 2026 08:55AM SciSparc: Subsidiary NeuroThera Labs Reports Positive Progress in FDA-Approved Phase IIb Clinical Trial for Tourette Syndrome
Oct 7, 2026 08:22AM SciSparc unit reports GPU speedup in gene combination analysis
Oct 7, 2026 08:22AM SciSparc: Subsidiary NeuroThera Labs’ CliniQuantum Reports Successful Quantum-Enabled Analysis of Billions of Gene Combinations Using Real-World Clinical Data on an S&P 500 Company’s Quantum Archi
Oct 7, 2026 08:22AM SciSparc: Subsidiary NeuroThera Labs’ CliniQuantum Reports Successful Quantum-Enabled Analysis of Billions of Gene Combinations Using Real-World Clinical Data on an S&P 500 Company’s Quantum A
Sep 23, 2026 08:35AM NeuroThera files 3 U.S. patents on LSD, ketamine, ibogaine combos
Sep 23, 2026 08:35AM SciSparc: Subsidiary NeuroThera Highlights Enhancement of U.S. Patent Portfolio Through Collaboration with Clearmind Covering LSD, Ketamine and Ibogaine Combinations
Sep 2, 2026 08:17AM SciSparc: Subsidiary NeuroThera Labs Pursues FDA Orphan Drug Designation For Adult Tourette Syndrome Drug; Engages Government and Public Affairs Firm RK Strategies
Jul 29, 2026 08:32AM SciSparc: Subsidiary NeuroThera Labs Advances its Quantum Platform for Clinical Data Analytics on a Platform of an S&P 500 company
Mar 13, 2026 07:46AM Clearmind Medicine files Hong Kong patent for depression therapy combo
Mar 13, 2026 07:45AM Clearmind Medicine Announces Hong Kong Patent Filing for Depression Therapy

SPRC and NTLX Related Press Releases

Go Back

Oct 22, 2026 08:55AM SciSparc: Subsidiary NeuroThera Labs Reports Positive Progress in FDA-Approved Phase IIb Clinical Trial for Tourette Syndrome
Oct 7, 2026 08:22AM SciSparc: Subsidiary NeuroThera Labs’ CliniQuantum Reports Successful Quantum-Enabled Analysis of Billions of Gene Combinations Using Real-World Clinical Data on an S&P 500 Company’s Quantum Archi
Oct 7, 2026 08:22AM SciSparc: Subsidiary NeuroThera Labs’ CliniQuantum Reports Successful Quantum-Enabled Analysis of Billions of Gene Combinations Using Real-World Clinical Data on an S&P 500 Company’s Quantum A
Sep 23, 2026 08:35AM SciSparc: Subsidiary NeuroThera Highlights Enhancement of U.S. Patent Portfolio Through Collaboration with Clearmind Covering LSD, Ketamine and Ibogaine Combinations
Sep 2, 2026 08:17AM SciSparc: Subsidiary NeuroThera Labs Pursues FDA Orphan Drug Designation For Adult Tourette Syndrome Drug; Engages Government and Public Affairs Firm RK Strategies
Jul 29, 2026 08:32AM SciSparc: Subsidiary NeuroThera Labs Advances its Quantum Platform for Clinical Data Analytics on a Platform of an S&P 500 company
Mar 13, 2026 07:45AM Clearmind Medicine Announces Hong Kong Patent Filing for Depression Therapy

SPRC and NTLX Related SEC Filings

Go Back